Minimal residual disease testing in multiple myeloma by flow cytometry: major heterogeneity

Journal article

Open access

Peer reviewed

Aaron Flanders, Maryalice Stetler-Stevenson, Ola Landgren and Carl Ola Landgren

Blood, Vol.122(6), pp.1088-1089

2013-08-08

PMCID: PMC3739032

PMID: 23929839

Abstract

Correspondence

url

https://doi.org/10.1182/blood-2013-05-506170View

Published (Version of record) Open

3 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics: 1 Clinical & Life Sciences; 1.130 Lymphomas; 1.130.617 Multiple Myeloma
Web Of Science research areas: Hematology
ESI research areas: Clinical Medicine

This output has contributed to the advancement of the following goals:

Source: InCites

Title: Minimal residual disease testing in multiple myeloma by flow cytometry: major heterogeneity
Creators: Aaron Flanders - National Cancer Institute
Maryalice Stetler-Stevenson - National Cancer Institute
Ola Landgren - National Cancer Institute
Carl Ola Landgren - Miller School of Medicine
Publication Details: Blood, Vol.122(6), pp.1088-1089
Publisher: American Society of Hematology
Grant note: National Institutes of Health
Academic Unit: Miller School of Medicine; UMMG Department of Medicine
Language: English
Resource Type: Journal article
PMID: 23929839
PMCID: PMC3739032
Record Identifier: 991031713916902976